Who are DaVita's decision-makers?
DaVita is led by Javier Rodriguez. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, compliance, finance, and operational stakeholders.
- CEO
- Javier Rodriguez
- CFO/key exec
- Joel Ackerman
- Founded
- 1999
- Employees
- 76,000+
- HQ
- Denver, CO
- Status
- NYSE: DVA
- Javier RodriguezChief Executive OfficerCEO since 2019Longtime DaVita executive leading dialysis and integrated kidney care.
- Joel AckermanChief Financial Officer and TreasurerCFO since 2017Finance leader for clinic economics and capital allocation.
- Kathleen WatersChief Legal and Public Affairs OfficerSenior executive leadershipLeads legal, compliance, and public-policy matters.
- Kenny GardnerChief People OfficerSenior executive leadershipWorkforce leader in a labor-intensive care model.
Who leads DaVita?
DaVita's leadership team combines enterprise healthcare operations, finance, clinical, product, technology, legal, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at DaVita?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, data-security, compliance, privacy, and implementation owners. Clinical, reimbursement, or quality stakeholders become essential whenever the purchase touches patient care, regulated data, medical products, or payer/provider economics.
How is DaVita organized as it scales?
DaVita operates through business units tied to U.S. dialysis, related lab and pharmacy services, integrated kidney care, and international operations. That creates multiple entry points, but enterprise standards for security, compliance, contracting, and vendor management can still control the final approval path.
As of June 2026.Sources:DaVita leadershipDaVita annual reports
DaVita — frequently asked questions
